U.S. federal rebound and early AI adoption fuel a recovery
- Cellebrite’s core buyer is government, with Public Sector Customers accounting for more than 90% of 2025 revenue.
- The business is mostly subscription based, with total license subscription revenue representing 90% of 2025 revenue.
- The company plans to redomicile to the United States to permanently eliminate foreign entity cloud procurement hurdles.
- Genesis secured $2 million in annual recurring revenue in its first full quarter, proving early demand for AI.
- U.S. federal demand accelerated back to 18% growth, ending a period of disruption in the segment.
Cloud clearance meets execution risk
The company rebounded strongly in the third quarter of 2026 after a mid year execution stumble. The critical U.S. federal segment returned to 18% growth, clearing up concerns about government spending freezes. To solve ongoing foreign entity procurement hurdles, the company announced plans to relocate its headquarters to the United States by the first half of 2027.
The bull case centers on massive market expansion through artificial intelligence. The Genesis AI product proved to be an immediate success, securing $2 million in annual recurring revenue during its first full quarter. Management believes the investigative AI market could reach roughly $12.5 billion over four years, which could easily double the size of the current business.
The bear case asks if this new product momentum can overcome isolated problem areas. The Corellium acquisition is deteriorating under a prolonged national security review, causing higher customer churn and freezing new sales. Additionally, as more customers finish upgrading to the Inseyets platform, the company will get less pricing uplift to drive near term growth. Profit margins also face ongoing pressure from a stronger Israeli shekel.
Software sold to agencies
Cellebrite sells software to public sector agencies and some private companies. Public sector work is the center of the business. The 2025 filing says Public Sector Customers accounted for more than 90% of total revenue, and no single organization made up more than 5% of 2025 revenue.
Most sales are subscriptions. Customers pay for term licenses, software applications, support, and maintenance. Total license subscription revenue represented 90% of 2025 revenue, up from 88% in 2024. This makes revenue more repeatable than a pure hardware or services model. The launch of Genesis introduced a consumption based token model, adding flexible usage revenue.
The model works best when an agency starts with digital forensics and then adds tools for evidence storage, analytics, case management, and artificial intelligence. That is why Inseyets migration, Guardian adoption, and Genesis conversion are the key moving parts.
Where it can break is budget timing and permissions. Many buyers are government agencies, so spending can pause during program changes or audits. Being a foreign entity recently added procurement hurdles for cloud adoption in the U.S. and Europe, prompting the company to announce a planned relocation to the United States.
From phones to full cases
Inseyets
Inseyets is the core digital forensics suite used to collect and review evidence from phones, computers, cloud apps, and vehicles. Management said 75% of the installed digital forensics base had converted to Inseyets by the end of Q3 2026.
Advanced lawful access
These tools help authorized users access locked devices under legal authority. They are valuable but sit closest to regulatory and device maker friction.
Guardian Forensics and Guardian Collaborate
Guardian products help store, share, review, and manage digital evidence. They push Cellebrite from device extraction into the larger workflow around a case.
Guardian Investigate
Guardian Investigate is an AI powered system of record for case management. It is now in general availability and forms a major piece of the growth strategy.
Genesis
Genesis is Cellebrite’s agentic AI product for faster data insight. It operates on a consumption based token model and secured $2 million in annual recurring revenue in its first full quarter.
Corellium
Corellium adds virtualization software for mobile security research and vulnerability work. The business is currently facing high churn while it awaits U.S. national security approval.
SCG Canada drone forensics
SCG Canada gives Cellebrite tools to extract, decode, and view evidence from common drones. The acquisition adds an immediate entry into a growing market.
Subscription carries the mix
The structured mix uses fiscal 2025 revenue lines from the 2025 Form 20-F because the available filing section discloses revenue by type. Geography is still important, as the Americas is the largest region and U.S. federal growth recently accelerated to 18%.
What could still go wrong
Foreign entity status limits sales
High impact · Medium oddsCellebrite is currently a foreign entity, which triggers extra review for cloud software contracts. The company plans to redomicile to the United States in 2027 to eliminate this friction. If the move is delayed or fails to satisfy regulators, growth could stall again.
AI adoption hits a wall
High impact · Medium oddsGenesis has early usage and generated $2 million in revenue in its first full quarter. However, the hard part is mass adoption. Management has a very large revenue target for artificial intelligence tools. If trial users do not become permanent paid seats, the story will stall.
Corellium struggles under review
Medium impact · High oddsThe Corellium business is deteriorating under a prolonged U.S. national security review. This review is causing higher customer churn and freezing new sales. Strict regulatory limits could permanently damage the value of the acquisition.
Device access becomes harder
High impact · Medium oddsCellebrite relies on keeping pace with new phone hardware, operating systems, encryption, and app changes. Regulators and device makers can also push back on tools that access locked or protected data.
Shekel strength pinches margins
Low impact · High oddsCellebrite reports in dollars, but a meaningful part of its costs are in Israeli shekels. A stronger shekel raises dollar reported expenses and can compress profit margins. Management calls this an ongoing near term headwind.
In one breath
What does Cellebrite actually do?
Cellebrite sells software that helps authorized users collect, decode, manage, and analyze digital evidence. Its main customers are law enforcement, defense, intelligence, and other public sector agencies.
Why does FedRAMP matter for Cellebrite?
FedRAMP is a U.S. government cloud security approval. Cellebrite received FedRAMP High authorization in May 2026, which makes it easier for federal agencies to buy and use its cloud products for sensitive data.
Is Cellebrite an AI company now?
Artificial intelligence is becoming a big part of the story through products like Genesis and Guardian Investigate. The core business is still digital forensics, but management believes AI could eventually double the total addressable market.
What is the biggest risk for CLBT stock?
The biggest risk is execution around government sales. The stock relies heavily on smooth government spending, and the company is currently working to redomicile to the United States to fix procurement hurdles.
Sources and research notes
This page combines Finn's company research with public filings and other cited materials. The thesis is reviewed when material company information changes; Finn Scores use the latest available scoring data.
- Thesis reviewed
- November 15, 2026
- Score data
- November 15, 2026
- Reviewed by
- Shivam Bharuka
Comparable Software - Infrastructure companies
Companies near Cellebrite DI Ltd. in Finn's Software - Infrastructure industry ranking.

